# The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD)

> **NCT03914378** · — · RECRUITING · sponsor: **University of Manchester** · enrollment: 100 (estimated)

## Conditions studied

- Head and Neck Neoplasms
- Hearing Loss

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03914378
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914378, "The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03914378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*